Mirae Asset Global Investments
CORT icon

Mirae Asset Global Investments’s Corcept Therapeutics CORT Stock Holding History

Mirae Asset Global Investments’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-37,726
Closed -$824K – 1741
2024
Q1 		$824K Hold
37,726
– – ﹤0.01% 1643
2023
Q4 		$1.23M Hold
37,726
– – ﹤0.01% 1515
2023
Q3 		$1.03M Hold
37,726
– – ﹤0.01% 1510
2023
Q2 		$839K Hold
37,726
– – ﹤0.01% 1673
2023
Q1 		$817K Buy
37,726
+862
+2% +$18.9K ﹤0.01% 1645
2022
Q4 		$749K Hold
36,864
– – ﹤0.01% 1666
2022
Q3 		$945K Buy
36,864
+10,880
+42% +$291K ﹤0.01% 1512
2022
Q2 		$618K Buy
+25,984
New +$566K ﹤0.01% 1650

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Mirae Asset Global Investments's CORT Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Corcept Therapeutics (CORT) in Q2 2024, closing a stake of 37,726 shares — an estimated $824K sold.

Mirae Asset Global Investments first reported a position in CORT in Q2 2022 and held it in 8 quarters. The position peaked at $1.23M in Q4 2023. 286 funds tracked by Wall St. Rank hold CORT as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Corcept Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 37,726 Corcept Therapeutics shares in Q2 2024, an estimated $824K.
  • Mirae Asset Global Investments first reported a position in Corcept Therapeutics in Q2 2022 and held it in 8 quarters.
  • Mirae Asset Global Investments's Corcept Therapeutics position peaked at $1.23M in Q4 2023.
  • 286 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.